Literature DB >> 16187498

Molecular cloning and characterization of a novel mannose-binding lectin cDNA from Zantedeschia aethiopica.

Zhonghai Chen1, Yongzhen Pang, Xiaojun Liu, Xinglong Wang, Zhongxiang Deng, Xiaofen Sun, Kexuan Tang.   

Abstract

Using RNA extracted from Zantedeschia aethiopica young leaves and primers designed according to the conservative regions of Araceae lectins, the full-length cDNA of Z. aethiopica agglutinin (ZAA) was cloned by rapid amplification of cDNA ends (RACE). The full-length cDNA of zaa was 871 bp and contained a 417 bp open reading frame (ORF) encoding a lectin precursor of 138 amino acids. Through comparative analysis of zaa gene and its deduced amino acid sequence with those of other Araceae species, it was found that zaa encoded a precursor lectin with signal peptide. Secondary and three-dimensional structure analyses showed that ZAA had many common characters of mannose-binding lectin superfamily and ZAA was a mannose-binding lectin with three mannose-binding sites. Southern blot analysis of the genomic DNA revealed that zaa belonged to a multi-copy gene family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187498

Source DB:  PubMed          Journal:  Biocell        ISSN: 0327-9545            Impact factor:   1.254


  3 in total

Review 1.  Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (GNA)-related lectins.

Authors:  Lei Wu; Jin-Ku Bao
Journal:  Glycoconj J       Date:  2012-08-15       Impact factor: 2.916

2.  Expression and purification of Zantedeschia aethiopica agglutinin in Escherichia coli.

Authors:  Ling Lin; Xue-Fen Liu; Ling-Chuan Hu; Yin Zhou; Xiao-Fen Sun; Ke-Xuan Tang
Journal:  Mol Biol Rep       Date:  2007-12-16       Impact factor: 2.316

Review 3.  Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.

Authors:  Annick Barre; Els J M Van Damme; Mathias Simplicien; Sophie Le Poder; Bernard Klonjkowski; Hervé Benoist; David Peyrade; Pierre Rougé
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.